Southeast Alaska Regional Health Consortium
Southeast Alaska Regional Health Consortium was paid $59.75M by Medicaid between Jan 2018 and Dec 2024, across 206 billing codes. Its largest line is 87635, Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe — 30% of everything it billed.
33Billing provider infoSOUTHEAST ALASKA REGIONAL HEALTH CONSORTIUM
SITKA, AK 99835
SITKA, AK 99835
33aNPI1720062524assigned 12/05/2005
33bProvider typePodiatrist
28Total paid$59.75M
24GClaims244,653
24DCodes billed206
24AFirst – last monthJan 2018 – Dec 2024
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official HARRIS, DANIEL controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 25,537 | $3.64M | |
| 2019 | 28,890 | $4.11M | |
| 2020 | 35,664 | $7.04M | |
| 2021 | 51,713 | $17.22M | |
| 2022 | 35,665 | $11.10M | |
| 2023 | 37,032 | $8.20M | |
| 2024incomplete | 30,152 | $8.44M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 30% | 26,587 | 18,356 | $17.80M |
| 80053 | Comprehensive metabolic panel | 7.4% | 9,698 | 7,940 | $4.43M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.6% | 14,652 | 12,387 | $3.93M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.8% | 11,544 | 9,844 | $2.89M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 4.5% | 11,115 | 7,021 | $2.71M |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3.4% | 4,551 | 4,215 | $2.06M |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 3.4% | 3,126 | 2,222 | $2.04M |
| 87086 | Culture, bacterial; quantitative colony count, urine | 3.3% | 4,778 | 4,275 | $1.98M |
| 87081 | 2.7% | 2,661 | 2,482 | $1.61M | |
| 84443 | Thyroid stimulating hormone (TSH) | 2.6% | 9,639 | 8,869 | $1.55M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.8% | 2,965 | 2,506 | $1.08M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 1.4% | 6,422 | 4,249 | $809K |
194 more codes
| 87070 | 1.3% | 1,505 | $788K | |
| 81003 | 1.3% | 2,449 | $782K | |
| 82728 | 1.3% | 2,408 | $769K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.1% | 2,377 | $674K |
| 86592 | 1.0% | 1,695 | $599K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,192 | $579K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 788 | $520K |
| 86140 | <1% | 2,829 | $485K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,359 | $453K |
| 80306 | <1% | 1,840 | $440K | |
| 84439 | <1% | 1,548 | $428K | |
| 99284 | Emergency room visit (serious) | <1% | 4,909 | $426K |
| 85610 | <1% | 2,159 | $424K | |
| 82607 | <1% | 1,902 | $411K | |
| 82043 | <1% | 847 | $402K | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 10,281 | $397K |
| 81001 | <1% | 1,900 | $394K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 10,076 | $394K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 991 | $386K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 893 | $383K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,941 | $355K |
| 81025 | <1% | 1,340 | $329K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,069 | $315K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,901 | $312K |
| 80061 | Lipid panel | <1% | 4,868 | $302K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 882 | $285K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,078 | $268K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 534 | $266K |
| 99285 | Emergency room visit (most serious) | <1% | 1,756 | $252K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 933 | $225K |
| 82570 | <1% | 1,571 | $201K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 2,155 | $197K |
| J3490 | Unclassified drugs | <1% | 3,834 | $195K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 556 | $184K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,640 | $179K |
| 82652 | <1% | 390 | $177K | |
| 99443 | <1% | 1,427 | $157K | |
| 93268 | <1% | 254 | $147K | |
| 87522 | Neg quan hep c or qual rna | <1% | 420 | $127K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 169 | $120K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 2,146 | $118K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,474 | $118K |
| 83540 | <1% | 2,111 | $114K | |
| 92015 | Determination of refractive state | <1% | 2,798 | $97K |
| 90686 | <1% | 971 | $82K | |
| 86850 | <1% | 564 | $80K | |
| 86803 | <1% | 1,619 | $78K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 197 | $69K |
| 84153 | <1% | 177 | $63K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 391 | $62K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 226 | $49K |
| 83735 | <1% | 2,977 | $47K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 147 | $44K |
| 87088 | <1% | 66 | $40K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 272 | $39K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,266 | $39K |
| 92552 | <1% | 72 | $35K | |
| 83880 | <1% | 155 | $33K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 55 | $33K |
| 87077 | <1% | 47 | $32K | |
| 83690 | <1% | 647 | $29K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 443 | $29K |
| 82670 | <1% | 69 | $27K | |
| 86580 | <1% | 95 | $27K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 980 | $26K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 567 | $25K |
| 80076 | <1% | 120 | $24K | |
| 99442 | <1% | 206 | $21K | |
| 87340 | <1% | 692 | $21K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 151 | $21K |
| 97010 | <1% | 85 | $20K | |
| 84702 | <1% | 50 | $20K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,553 | $18K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,735 | $18K |
| 0002A | <1% | 379 | $18K | |
| 83001 | <1% | 85 | $18K | |
| 0011A | <1% | 46 | $18K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 60 | $17K |
| 86708 | <1% | 161 | $16K | |
| 92567 | <1% | 271 | $15K | |
| 82105 | <1% | 25 | $15K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 34 | $15K |
| 99243 | <1% | 42 | $14K | |
| 92557 | <1% | 79 | $14K | |
| 85651 | <1% | 384 | $14K | |
| 82785 | <1% | 27 | $13K | |
| 73610 | <1% | 28 | $12K | |
| 0001A | <1% | 398 | $12K | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 212 | $12K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 28 | $11K |
| 86038 | <1% | 157 | $11K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,032 | $11K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 167 | $11K |
| V5266 | Battery for use in hearing device | <1% | 18 | $10K |
| 82274 | <1% | 17 | $10K | |
| 86480 | <1% | 29 | $10K | |
| 84403 | <1% | 39 | $9K | |
| 82784 | <1% | 30 | $9K | |
| 86900 | <1% | 671 | $9K | |
| 11721 | <1% | 39 | $9K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 86 | $9K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 135 | $8K |
| 85027 | <1% | 118 | $8K | |
| 82947 | <1% | 18 | $8K | |
| 82746 | <1% | 272 | $8K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 13 | $7K |
| 85730 | <1% | 1,086 | $7K | |
| 80074 | <1% | 58 | $7K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 33 | $7K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 98 | $6K |
| 83655 | <1% | 13 | $6K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 13 | $6K |
| 97161 | <1% | 141 | $6K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 184 | $6K |
| 86317 | <1% | 152 | $5K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 17 | $5K |
| 84100 | <1% | 354 | $5K | |
| 84146 | <1% | 30 | $5K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 61 | $5K |
| 84155 | <1% | 24 | $4K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 102 | $4K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 14 | $4K |
| 73030 | <1% | 12 | $4K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 275 | $4K |
| 91320 | <1% | 14 | $3K | |
| 86003 | <1% | 119 | $3K | |
| 87205 | <1% | 704 | $3K | |
| 86695 | <1% | 19 | $3K | |
| 83550 | <1% | 2,064 | $3K | |
| G0378 | Hospital observation service, per hour | <1% | 738 | $3K |
| 84484 | <1% | 401 | $3K | |
| 97802 | <1% | 16 | $3K | |
| 0004A | <1% | 82 | $3K | |
| 92555 | <1% | 71 | $2K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,376 | $2K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 861 | $2K |
| 93000 | <1% | 20 | $2K | |
| 86431 | <1% | 47 | $2K | |
| 84144 | <1% | 13 | $2K | |
| 87186 | <1% | 63 | $2K | |
| 90750 | <1% | 12 | $2K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 28 | $2K |
| 83516 | <1% | 58 | $2K | |
| 99221 | <1% | 13 | $2K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 786 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 17 | $1K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 89 | $1K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 135 | $1K |
| 84481 | <1% | 31 | $1K | |
| 82627 | <1% | 14 | $1K | |
| 86762 | <1% | 85 | $989.97 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 21 | $866.86 |
| 83615 | <1% | 15 | $808.00 | |
| 97162 | <1% | 18 | $763.20 | |
| 71045 | Radiologic examination, chest; single view | <1% | 13 | $710.00 |
| 87210 | <1% | 22 | $710.00 | |
| 86901 | <1% | 674 | $653.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 17 | $653.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 29 | $620.35 |
| 82150 | <1% | 15 | $620.35 | |
| 99349 | <1% | 13 | $594.46 | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 44 | $517.89 |
| 0071A | <1% | 14 | $420.06 | |
| 92250 | <1% | 16 | $289.37 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 201 | $10.08 |
| 80320 | 0% | 666 | $0.00 | |
| 90656 | 0% | 63 | $0.00 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 0% | 27 | $0.00 |
| 83605 | 0% | 154 | $0.00 | |
| 90480 | 0% | 127 | $0.00 | |
| 91301 | 0% | 60 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 106 | $0.00 |
| 85379 | 0% | 14 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 0% | 200 | $0.00 |
| T1023 | Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter | 0% | 25 | $0.00 |
| 99217 | 0% | 32 | $0.00 | |
| 91307 | 0% | 23 | $0.00 | |
| 87147 | 0% | 28 | $0.00 | |
| J3411 | Injection, thiamine hcl, 100 mg | 0% | 18 | $0.00 |
| 92310 | 0% | 63 | $0.00 | |
| 84703 | 0% | 15 | $0.00 | |
| 91322 | 0% | 48 | $0.00 | |
| 91300 | 0% | 1,070 | $0.00 | |
| H2021 | Community-based wrap-around services, per 15 minutes | 0% | 366 | $0.00 |
| S0164 | Injection, pantoprazole sodium, 40 mg | 0% | 20 | $0.00 |
| 86696 | 0% | 19 | $0.00 | |
| 91312 | 0% | 26 | $0.00 | |
| 84156 | 0% | 49 | $0.00 | |
| 0003A | 0% | 14 | $0.00 | |
| 90715 | 0% | 27 | $0.00 | |
| 0124A | 0% | 36 | $0.00 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 0% | 15 | $0.00 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 0% | 13 | $0.00 |
| 84450 | 0% | 46 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHARRIS, DANIEL (CHIEF FINANCIAL OFFICER)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.